MedTrace Logo

Role of Surgery in Advanced Ovarian Cancer

NCT03980028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2019-06-10

No results posted yet for this study

Summary

To demonstrate that ultra-radical surgery with multiple visceral resections and high tumor burden prior to surgery independently reduces the survival of patients with advanced ovarian cancer treated with complete cytoreductive surgery.

Conditions

Sponsors & Collaborators

  • Institut Bergonié

    collaborator OTHER

  • Institut Paoli-Calmettes

    collaborator OTHER

  • Institut du Cancer de Montpellier - Val d'Aurelle

    collaborator OTHER

  • Hospital Universitario La Paz

    collaborator OTHER

  • Hospital Vall d'Hebron

    collaborator OTHER

  • Institut Claudius Regaud

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-01-01
Completion
2019-06-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03980028 on ClinicalTrials.gov